Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer

被引:20
作者
Linares-Galiana, Isabel [1 ,2 ]
Berenguer-Frances, Miguel Angel [1 ,2 ]
Canas-Cortes, Rut [2 ]
Pujol-Canadell, Monica [2 ]
Comas-Anton, Silvia [3 ]
Martinez, Evelyn [1 ]
Laplana, Maria [1 ]
Perez-Montero, Hector [1 ]
Pla-Farnos, Maria Jesus [4 ]
Navarro-Martin, Arturo [1 ,2 ]
Nunez, Miriam [1 ,2 ]
Both, Brigitte [5 ]
Guedea, Ferran [1 ,2 ]
机构
[1] Hosp Duran & Reynals, Inst Catala Oncol ICO, Radiat Oncol Dept, Avinguda Gran Via Hosp 199-203, Barcelona 08098, Spain
[2] Inst Invest Biomed Bellvitge IDIBELL, ONCOBELL Program, Radiobiol & Canc Grp, Avinguda Gran Via Hosp 199-203, Barcelona 08098, Spain
[3] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol ICO, Radiat Oncol Dept, Carretera Canyet S-N, Badalona 08916, Spain
[4] Hosp Univ Bellvitge, Gynecol Dept, Carrer Feixa Llarga S-N, Barcelona 08907, Spain
[5] Carl Zeiss Meditec AG, ZEISS Grp, Business Sect Radiotherapy, Med Technol Business Grp,Med Affairs & Proff Educ, Rudolf Eber Str 11, Oberkochen, Germany
关键词
immune system; immunomodulation; flow cytometry; immunophenotyping; breast cancer; intraoperative radiation therapy; NK CELLS; RADIOTHERAPY; IRRADIATION;
D O I
10.1093/jrr/rraa083
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A detailed understanding of the interactions and the best dose-fractionation scheme of radiation to maximize antitumor immunity have not been fully established. In this study, the effect on the host immune system of a single dose of 20 Gy through intraoperative radiation therapy (IORT) on the surgical bed in low-risk breast cancer patients undergoing conserving breast cancer has been assessed. Peripheral blood samples from 13 patients were collected preoperatively and at 48 h and 3 and 10 weeks after the administration of radiation. We performed a flow cytometry analysis for lymphocyte subpopulations, natural killer cells (NK), regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSCs). We observed that the subpopulation of NK CD56(+high) CD16(+) increased significantly at 3 weeks after IORT (0.30-0.42%, P < 0.001), while no changes were found in immunosuppressive profile, CD4(+) CD25(+) Foxp3(+)Helios(+) Treg cells, granulocyticMDSCs (G-MDSCs) andmonocyticMDSCs (Mo-MDSCs). A single dose of IORT may be an effective approach to improve antitumor immunity based on the increase in NK cells and the non-stimulation of immunosuppressive cells involved in immune escape. These findings support future combinations of IORT with immunotherapy, if they are confirmed in a large cohort of breast cancer patients.
引用
收藏
页码:110 / 118
页数:9
相关论文
共 42 条
  • [1] Natural and induced T regulatory cells in cancer
    Adeegbe, Dennis O.
    Nishikawa, Hiroyoshi
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [2] Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer
    Andre, Fabrice
    Dieci, Maria V.
    Dubsky, Peter
    Sotiriou, Christos
    Curigliano, Giuseppe
    Denkert, Carsten
    Loi, Sherene
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (01) : 28 - 33
  • [3] The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
    Barker, Holly E.
    Paget, James T. E.
    Khan, Aadil A.
    Harrington, Kevin J.
    [J]. NATURE REVIEWS CANCER, 2015, 15 (07) : 409 - 425
  • [4] Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding
    Belletti, Barbara
    Vaidya, Jayant S.
    D'Andrea, Sara
    Entschladen, Frank
    Roncadin, Mario
    Lovat, Francesca
    Berton, Stefania
    Perin, Tiziana
    Candiani, Ezio
    Reccanello, Sonia
    Veronesi, Andrea
    Canzonieri, Vincenzo
    Trovo, Mauro G.
    Zaenker, Kurt S.
    Colombatti, Alfonso
    Baldassarre, Gustavo
    Massarut, Samuele
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1325 - 1332
  • [5] Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy
    Bos, Paula D.
    Plitas, George
    Rudra, Dipayan
    Lee, Sue Y.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (11) : 2435 - 2446
  • [6] Radiation for awakening the dormant immune system, a promising challenge to be explored
    de la Cruz-Merino, Luis
    Illescas-Vacas, Ana
    Grueso-Lopez, Ana
    Barco-Sanchez, Antonio
    Miguez-Sanchez, Carlos
    [J]. FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [7] Role of Local Radiation Therapy in Cancer Immunotherapy
    Demaria, Sandra
    Golden, Encouse B.
    Formenti, Silvia C.
    [J]. JAMA ONCOLOGY, 2015, 1 (09) : 1325 - 1332
  • [8] Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials
    Early Breast Cancer Trialists' Collaborative Group
    [J]. LANCET, 2000, 355 (9217) : 1757 - 1770
  • [9] Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway
    Fabris, L.
    Berton, S.
    Citron, F.
    D'Andrea, S.
    Segatto, I.
    Nicoloso, M. S.
    Massarut, S.
    Armenia, J.
    Zafarana, G.
    Rossi, S.
    Ivan, C.
    Perin, T.
    Vaidya, J. S.
    Avanzo, M.
    Roncadin, M.
    Schiappacassi, M.
    Bristow, R. G.
    Calin, G.
    Baldassarre, G.
    Belletti, B.
    [J]. ONCOGENE, 2016, 35 (37) : 4914 - 4926
  • [10] The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
    Finkelstein, Steven Eric
    Timmerman, Robert
    McBride, WilliamH.
    Schaue, Doerthe
    Hoffe, Sarah E.
    Mantz, Constantine A.
    Wilson, George D.
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,